免疫療法薬のグローバル市場2024-2028:病院、診療所、その他

【英語タイトル】Global Immunotherapy Drugs Market 2024-2028

Technavioが出版した調査資料(IRTNTR76823-24)・商品コード:IRTNTR76823-24
・発行会社(調査会社):Technavio
・発行日:2023年11月17日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

免疫療法薬の世界市場 2024-2028免疫療法薬市場は2023〜2028年に1,113億5,000万米ドル成長し、予測期間中のCAGRは11.31%で加速すると予測されます。当レポートでは、免疫療法薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、癌の有病率の増加、製薬技術への投資の増加、患者の意識の高まりによって牽引されています。

Technavio社の免疫療法薬市場は以下のように分類されます:
エンドユーザー別
- 病院
- 診療所
- その他

タイプ別
- モノクローナル抗体
- ワクチン
- 免疫チェックポイント阻害剤
- その他

地域別
- 北米
- 欧州
- アジア
- その他の地域(ROW)

本調査では、今後数年間における免疫療法薬市場の成長を促進する主な要因の一つとして、新たな薬剤開発技術を挙げています。また、個別化医療製品への注目の高まりや、腫瘍学以外の分野への応用拡大も、市場の大きな需要につながるでしょう。

免疫療法薬市場に関するレポートは以下の分野をカバーしています:
- 免疫療法薬市場の規模
- 免疫療法薬市場予測
- 免疫療法薬市場の産業分析

本レポートでは、免疫療法薬市場の主要ベンダーであるAbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, BioNTech SE, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celldex Therapeutics Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Immatics NV, Incyte Corp., Johnson and Johnson, Novartis AG, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., ElevateBio, and Genmab AS.などを分析しています。また、免疫療法薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場概況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 世界の免疫療法薬市場規模:エンドユーザー別分析
7 世界の免疫療法薬市場規模:種類別分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global immunotherapy drugs market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global immunotherapy drugs market 2018 – 2022 ($ billion)
o 4.2 End-user Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – End-user Segment 2018 – 2022 ($ billion)
o 4.3 Type Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Type Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2023-2028 (%)
o Exhibit 31: Data Table on End-user – Market share 2023-2028 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals – Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospitals – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Hospitals – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Hospitals – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospitals – Year-over-year growth 2023-2028 (%)
o 6.4 Clinics – Market size and forecast 2023-2028
o Exhibit 38: Chart on Clinics – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Clinics – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Clinics – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Clinics – Year-over-year growth 2023-2028 (%)
o 6.5 Others – Market size and forecast 2023-2028
o Exhibit 42: Chart on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ billion)
o Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Type – Market share 2023-2028 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Monoclonal antibodies – Market size and forecast 2023-2028
o Exhibit 52: Chart on Monoclonal antibodies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Monoclonal antibodies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Monoclonal antibodies – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Monoclonal antibodies – Year-over-year growth 2023-2028 (%)
o 7.4 Vaccines – Market size and forecast 2023-2028
o Exhibit 56: Chart on Vaccines – Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Vaccines – Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Vaccines – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Vaccines – Year-over-year growth 2023-2028 (%)
o 7.5 Immune checkpoint inhibitors – Market size and forecast 2023-2028
o Exhibit 60: Chart on Immune checkpoint inhibitors – Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Immune checkpoint inhibitors – Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Immune checkpoint inhibitors – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Immune checkpoint inhibitors – Year-over-year growth 2023-2028 (%)
o 7.6 Others – Market size and forecast 2023-2028
o Exhibit 64: Chart on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 7.7 Market opportunity by Type
o Exhibit 68: Market opportunity by Type ($ billion)
o Exhibit 69: Data Table on Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 75: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 91: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 95: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 99: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 103: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 107: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. – Overview
o Exhibit 120: AbbVie Inc. – Product / Service
o Exhibit 121: AbbVie Inc. – Key news
o Exhibit 122: AbbVie Inc. – Key offerings
o 12.4 Amgen Inc.
o Exhibit 123: Amgen Inc. – Overview
o Exhibit 124: Amgen Inc. – Product / Service
o Exhibit 125: Amgen Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 126: AstraZeneca Plc – Overview
o Exhibit 127: AstraZeneca Plc – Product / Service
o Exhibit 128: AstraZeneca Plc – Key news
o Exhibit 129: AstraZeneca Plc – Key offerings
o 12.6 Bayer AG
o Exhibit 130: Bayer AG – Overview
o Exhibit 131: Bayer AG – Business segments
o Exhibit 132: Bayer AG – Key news
o Exhibit 133: Bayer AG – Key offerings
o Exhibit 134: Bayer AG – Segment focus
o 12.7 BioNTech SE
o Exhibit 135: BioNTech SE – Overview
o Exhibit 136: BioNTech SE – Product / Service
o Exhibit 137: BioNTech SE – Key offerings
o 12.8 Boehringer Ingelheim International GmbH
o Exhibit 138: Boehringer Ingelheim International GmbH – Overview
o Exhibit 139: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 140: Boehringer Ingelheim International GmbH – Key news
o Exhibit 141: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 142: Boehringer Ingelheim International GmbH – Segment focus
o 12.9 Bristol Myers Squibb Co.
o Exhibit 143: Bristol Myers Squibb Co. – Overview
o Exhibit 144: Bristol Myers Squibb Co. – Product / Service
o Exhibit 145: Bristol Myers Squibb Co. – Key news
o Exhibit 146: Bristol Myers Squibb Co. – Key offerings
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 147: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 148: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 149: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 150: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 151: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 Gilead Sciences Inc.
o Exhibit 152: Gilead Sciences Inc. – Overview
o Exhibit 153: Gilead Sciences Inc. – Product / Service
o Exhibit 154: Gilead Sciences Inc. – Key news
o Exhibit 155: Gilead Sciences Inc. – Key offerings
o 12.12 GlaxoSmithKline Plc
o Exhibit 156: GlaxoSmithKline Plc – Overview
o Exhibit 157: GlaxoSmithKline Plc – Business segments
o Exhibit 158: GlaxoSmithKline Plc – Key news
o Exhibit 159: GlaxoSmithKline Plc – Key offerings
o Exhibit 160: GlaxoSmithKline Plc – Segment focus
o 12.13 Immatics NV
o Exhibit 161: Immatics NV – Overview
o Exhibit 162: Immatics NV – Product / Service
o Exhibit 163: Immatics NV – Key offerings
o 12.14 Johnson and Johnson
o Exhibit 164: Johnson and Johnson – Overview
o Exhibit 165: Johnson and Johnson – Business segments
o Exhibit 166: Johnson and Johnson – Key news
o Exhibit 167: Johnson and Johnson – Key offerings
o Exhibit 168: Johnson and Johnson – Segment focus
o 12.15 Novartis AG
o Exhibit 169: Novartis AG – Overview
o Exhibit 170: Novartis AG – Business segments
o Exhibit 171: Novartis AG – Key offerings
o Exhibit 172: Novartis AG – Segment focus
o 12.16 Pfizer Inc.
o Exhibit 173: Pfizer Inc. – Overview
o Exhibit 174: Pfizer Inc. – Product / Service
o Exhibit 175: Pfizer Inc. – Key news
o Exhibit 176: Pfizer Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 177: Sanofi SA – Overview
o Exhibit 178: Sanofi SA – Business segments
o Exhibit 179: Sanofi SA – Key news
o Exhibit 180: Sanofi SA – Key offerings
o Exhibit 181: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global immunotherapy drugs market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – End-user Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Type Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on End-user – Market share 2023-2028 (%)
Exhibits31: Data Table on End-user – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospitals – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospitals – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Clinics – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Clinics – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Clinics – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Clinics – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Type – Market share 2023-2028 (%)
Exhibits49: Data Table on Type – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Monoclonal antibodies – Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Monoclonal antibodies – Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Monoclonal antibodies – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Monoclonal antibodies – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Vaccines – Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Vaccines – Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Vaccines – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Vaccines – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Immune checkpoint inhibitors – Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Immune checkpoint inhibitors – Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Immune checkpoint inhibitors – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Immune checkpoint inhibitors – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Others – Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Type ($ billion)
Exhibits69: Data Table on Market opportunity by Type ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. – Overview
Exhibits120: AbbVie Inc. – Product / Service
Exhibits121: AbbVie Inc. – Key news
Exhibits122: AbbVie Inc. – Key offerings
Exhibits123: Amgen Inc. – Overview
Exhibits124: Amgen Inc. – Product / Service
Exhibits125: Amgen Inc. – Key offerings
Exhibits126: AstraZeneca Plc – Overview
Exhibits127: AstraZeneca Plc – Product / Service
Exhibits128: AstraZeneca Plc – Key news
Exhibits129: AstraZeneca Plc – Key offerings
Exhibits130: Bayer AG – Overview
Exhibits131: Bayer AG – Business segments
Exhibits132: Bayer AG – Key news
Exhibits133: Bayer AG – Key offerings
Exhibits134: Bayer AG – Segment focus
Exhibits135: BioNTech SE – Overview
Exhibits136: BioNTech SE – Product / Service
Exhibits137: BioNTech SE – Key offerings
Exhibits138: Boehringer Ingelheim International GmbH – Overview
Exhibits139: Boehringer Ingelheim International GmbH – Business segments
Exhibits140: Boehringer Ingelheim International GmbH – Key news
Exhibits141: Boehringer Ingelheim International GmbH – Key offerings
Exhibits142: Boehringer Ingelheim International GmbH – Segment focus
Exhibits143: Bristol Myers Squibb Co. – Overview
Exhibits144: Bristol Myers Squibb Co. – Product / Service
Exhibits145: Bristol Myers Squibb Co. – Key news
Exhibits146: Bristol Myers Squibb Co. – Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. – Overview
Exhibits148: F. Hoffmann La Roche Ltd. – Business segments
Exhibits149: F. Hoffmann La Roche Ltd. – Key news
Exhibits150: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits152: Gilead Sciences Inc. – Overview
Exhibits153: Gilead Sciences Inc. – Product / Service
Exhibits154: Gilead Sciences Inc. – Key news
Exhibits155: Gilead Sciences Inc. – Key offerings
Exhibits156: GlaxoSmithKline Plc – Overview
Exhibits157: GlaxoSmithKline Plc – Business segments
Exhibits158: GlaxoSmithKline Plc – Key news
Exhibits159: GlaxoSmithKline Plc – Key offerings
Exhibits160: GlaxoSmithKline Plc – Segment focus
Exhibits161: Immatics NV – Overview
Exhibits162: Immatics NV – Product / Service
Exhibits163: Immatics NV – Key offerings
Exhibits164: Johnson and Johnson – Overview
Exhibits165: Johnson and Johnson – Business segments
Exhibits166: Johnson and Johnson – Key news
Exhibits167: Johnson and Johnson – Key offerings
Exhibits168: Johnson and Johnson – Segment focus
Exhibits169: Novartis AG – Overview
Exhibits170: Novartis AG – Business segments
Exhibits171: Novartis AG – Key offerings
Exhibits172: Novartis AG – Segment focus
Exhibits173: Pfizer Inc. – Overview
Exhibits174: Pfizer Inc. – Product / Service
Exhibits175: Pfizer Inc. – Key news
Exhibits176: Pfizer Inc. – Key offerings
Exhibits177: Sanofi SA – Overview
Exhibits178: Sanofi SA – Business segments
Exhibits179: Sanofi SA – Key news
Exhibits180: Sanofi SA – Key offerings
Exhibits181: Sanofi SA – Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations



★調査レポート[免疫療法薬のグローバル市場2024-2028:病院、診療所、その他] (コード:IRTNTR76823-24)販売に関する免責事項を必ずご確認ください。
★調査レポート[免疫療法薬のグローバル市場2024-2028:病院、診療所、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆